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Abstract
Background: Inherited Copy Number Variants (CNVs) can modulate the expression levels of individual genes.
However, little is known about how CNVs alter biological pathways and how this varies across different populations.
To trace potential evolutionary changes of well-described biological pathways, we jointly queried the genomes and
the transcriptomes of a collection of individuals with Caucasian, Asian or Yoruban descent combining
high-resolution array and sequencing data.
Results: We implemented an enrichment analysis of pathways accounting for CNVs and genes sizes and detected
significant enrichment not only in signal transduction and extracellular biological processes, but also in metabolism
pathways. Upon the estimation of CNV population differentiation (CNVs with different polymorphism frequencies
across populations), we evaluated that 22% of the pathways contain at least one gene that is proximal to a CNV
(CNV-gene pair) that shows significant population differentiation. The majority of these CNV-gene pairs belong to
signal transduction pathways and 6% of the CNV-gene pairs show statistical association between the copy number
states and the transcript levels.
Conclusions: The analysis suggested possible examples of positive selection within individual populations
including NF-kB, MAPK signaling pathways, and Alu/L1 retrotransposition factors. Altogether, our results suggest
that constitutional CNVs may modulate subtle pathway changes through specific pathway enzymes, which may
become fixed in some populations.
Keywords: CNVs, Pathways, Pathway evolution, Population genetics, eQTL
Background
The study of human genome variation over the last several
years has expanded from singlen u c l e o t i d ep o l y m o r p h i s m s
(SNPs) to structural variants (SVs) of which copy number
variants (CNVs) constitute a distinct class [1,2]. CNVs are
unbalanced SVs that are present in polymorphic copy num-
ber states, and include deletions, duplications, or combina-
tions thereof. Recently, a comprehensive population-wide
CNV map of the human genome was published [3]. The
authors reported on a large set of common CNVs (Minor
Allele Frequency (MAF) > 5%) greater than 1 kilobase (kb)
in length and genotyped 4,978 of them on 450 individuals
with ancestry in Europe, Africa or Asia (the HapMap
collection, http://www.hapmap.org). In addition, a recent
report from the 1000 Genome Project [4] included about
20,000 deletion polymorphisms (MAF > 1%) in the same
HapMap populations from European, African and
Asian ancestry, and genotypes were inferred for most
of the variants. Further Mills et al. characterized the
majority of these deletions at sequence level resolution
[5], and proposed a detailed map of SV hotspots formed
by common mechanisms.
CNVs have now been implicated with multiple common
human diseases (see [6,7] for comprehensive reviews)
including Crohn’s disease (20-kb deletion upstream IRGM)
[8], osteoporosis (117-kb deletion of UGT2B17) [9], body
mass index (45-kb deletion upstream of NEGR1)[10], and
decreased susceptibility to HIV (higher copy number of
CCL3L1) [11]. CNVs have also been shown to be associated
with high risk of autism [12,13], schizophrenia [14,15] and
cancer [16,17].
The effect of SNPs on gene expression was recently
described through extensive expression Quantitative Trait
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tions [18,19]. In 2007, Stranger et al. [20] performed tran-
scripts association analysis both with SNPs and with
CNVs, and highlighted similarities and differences for the
two types of variation. Recently, two independent studies
focused on the characterization of the potential impact of
CNVs on gene transcripts by systematically querying CNV
copy number states and paired gene expression levels
obtained by RNA sequencing on a common set of 129
individuals. Our group [21] queried more than 5,000
CNVs and showed that short CNVs (< 1 kb) and gains are
more likely to have functional impact with respect to
larger CNVs and deletions, respectively. Schlattl et al. [22]
observed that CNVs exhibit a stronger correlation with
expression than nearby SNPs and suggested a frequent
causal role of CNVs in expression quantitative trait loci.
Several human polymorphism studies, mainly based on
SNPs, have been undertaken to identify human genome
regions that are under selection (a summary of genome-
wide scans for positive selection can be found in Akey et al.
[23]; identification of areas of balancing selection and of
classic selective sweeps in Andres et al. [24] and Hernandez
et al. [25], respectively). The integrated map of positive
selection from Akey et al. [23] suggested that positive selec-
tion targets encompass ~14% of the human genome and
~23% of all UCSC RefSeq genes. In the context of SNPs,
the signature of positive selection includes a high propor-
tion of function-altering mutations, site frequency spectrum
with high frequency of the derived allele and low genetic
diversity (as a signature of complete or partial sweep),
different allele frequency between populations, and long
haplotypes [26]. In the context of CNVs, positive selection
could be suggested by allele frequencies that significantly
differ between populations and by linkage disequilibrium
with SNPs under positive selection [27,28]. Alternatively,
population differentiation could be a result of genetic drift,
however the latter is more significant for small populations
[29]. For instance, the salivary amylase gene (AMY1)c o p y
number varies considerably across populations and corre-
lates with dietary starch prevalence, which supports the
hypothesis of positive selection acting on AMY1 copy num-
ber in high-starch diet populations [30]. Another example
is the complex evolutionary history of the polymorphic
UGT2B17 gene that shows high population differentiation
[31] (see Additional file 1). Recently, RHOXF2 has been
reported as fast-evolving homeobox gene in primates
with rapid evolution and copy number changes driven
by Darwinian positive selection acting on the male
reproductive system [32].
Based on the observation of close genetic distances at the
nucleotide level between human and chimpanzee, the hy-
pothesis that regulatory mutations account for the majority
of biological differences was proposed as early as 1975 [33].
More recent work suggests that gene expression levels can
also serve as targets of selection [34]. In the past, few stu-
dies focused on individual genes’ substitution rates
(non-uniform across the genome) suggested that different
types of selection act on genes depending on their position
in the pathway [35,36]. Here, we posit more broadly that
pathways can be subjects for selection.
Existing models of pathway evolution, such as the
Horowitz retrograde model [37], the chemistry-driven
patchwork model [38], and others (see [39] for a review on
pathway evolution theories) consider major modifications
to a pathway chain, such as recruitment of a new enzyme
(new node) or a whole pathway duplication, that eventually
lead to creation of a new pathway. In addition to these
major changes, we argue that more subtle ones might play
an important role. Specifically, we hypothesize that fixed
changes in gene product concentration levels - resulting
from the changes in gene transcription levels - act as small
adjustments while we assume that the number of pathway
nodes and the pathway structure remain unchanged.
In this study, we performed an analysis of 491 well-
characterized biological pathways seeking to determine
how CNVs mapping to pathway genes impact transcript
levels and how this effect differs across populations. Our
results suggest that CNVs may modulate subtle changes
in pathways at specific nodes, which may become fixed in
certain populations. We propose a model of pathway
evolution where population differences are tuned at
finite nodal points. We discuss here the role of CNVs as
potential modulators of biological pathways in human
genome evolution.
Methods
CNVs and HapMap genotype data
The complete set of 11,700 CNV coordinates from [3] was
considered in the pathways enrichment/depletion analysis.
Based upon the availability of high-resolution data [3] at
single sample level, we considered genotype calls for 4,978
C N V sa n dt h e nu s e dt h i sa n n otated set for population
differentiation analysis. The sample set included 180 CEU
(Utah residents with ancestry from Northern and Western
Europe), 180 YRI (Yoruba from Ibadan, Nigeria), 45 JPT
(individuals from Tokyo, Japan), and 45 CHB (individuals
from Beijing, China) from the International HapMap
Consortium (http://www.hapmap.org). Throughout this
study, Japanese and Chinese individuals are collectively
referred to as Asian (ASN). All the data were downloaded
from Conrad et al. [3]. Classification of CNVs as gains and
losses was taken exactly as inferred in [3].
Gene annotation and pathway information
RefSeq Gene annotation information was downloaded
from the University of California-Santa Cruz (UCSC) Web
browser [40] as NCBI build 36 (hg18). The complete list
of pathways and corresponding genes was compiled from
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and Biocarta (http://www.biocarta.com).
F-statistics and CNV frequencies
Population differentiation was evaluated using the F-statistics
[42] that ranges between 0 (completely undifferentiated) and
1 (highly differentiated). F-statistics was calculated
for each population pair by considering each
CN genotype as an allele for diallelic CNVs as
in McCarroll et al. [43]. The F-statistics (Fst) was evalu-
ated as follows: Fst =( H t-Hs)/H t ;H t =1-
P
ti
2;t i =
(( x i ￿ Nx)+( y i ￿ Ny))/( N x+Ny); Hs =( (1 -
P
xi
2) ￿
Nx +( 1-
P
yi
2) ￿ Ny )/( N x+Ny), where xi and yi are the
population frequencies of allelic copy number i (i =A 0 ,A 1 ,
A2, A3, A4 or >A4) in population X and Y, respectively, Nx
and Ny denote the number of individuals in population X
and Y, and ti is a weighted average of xi and yi.T h i s
approach ignores the phase of the haplotype.
F-statistics cutoffs corresponding to the 5% and 1%
tails of the distributions built for each population pair
were considered. Specifically, the following values were
calculated and applied: Fst=0.19 (P<0.05) and Fst=0.32
(P<0.01) for CEU-YRI; Fst=0.2 (P<0.05) and Fst=0.36 for
(P<0.01) for YRI-ASN; Fst=0.14 (P<0.05) and Fst=0.24
(P<0.01) for CEU-ASN.
Beside the formal assessment of population differen-
t i a t i o nb ym e a n so ft h eF - s t a tistics, we considered the
frequency of polymorphisms, referred to as CNV frequency,
as the sum of the frequencies of all CN states that differ
from the major CN state. CNV frequencies are utilized in
the generation of frequency heatmaps. For consistency, we
selected the CEU major CN state for each CNV. This
choice does not affect the results as we focus on differences
rather than absolute values.
Size-dependent CNV enrichment/depletion analysis
Given a set of CNVs and a set of genes (e.g., gene families,
pathways, Gene Ontology (GO) categories), the approach
estimates if the number of observed CNV-gene overlaps is
significantly higher (enriched) or lower (depleted) than
what it would be expected by chance.To evaluate enrich-
ment or depletion of pathways for the presence of overlap-
ping CNVs, we developed a size-dependent enrichment
method that takes into account the sizes of genes and
CNVs and we empirically simulated the null distribution
through permutations. The approach overcomes the limita-
tion of commonly applied statistical tests that do not con-
sider either CNV or gene size information. In reality, gene
families widely differ in terms of gene sizes (e.g., the ETS
family of transcription factors and the keratin gene families
have average gene sizes of 55 kb and 3 megabases (Mb),
respectively). A schematic representation of this problem is
presented in Figure 1A where the blue (red) circles repre-
sent genes overlapping (not overlapping) with CNVs.
gene
CNV
C
A
B
flanking area
CNVs or parts that are excluded
Positioning of CNVs on transcriptome
Aligning of CNVs on the genome
Marking overlap and excluding CNVs from intergenic areas
Rules for CNV-gene pairing at the borders
Transcriptome and “resized” set of CNVs
Figure 1 Size-dependent enrichment analysis. A. Incorporation of
sizes into enrichment analysis. The size of the objects corresponds to
the probability of being drawn. B. Positioning of CNVs on
transcriptome. First, CNVs are aligned on the genome. Second, CNVs
or part of CNVs that fell outside of the gene areas are excluded or
truncated. Third, transcriptome and newly “resized” set of CNVs are
used for permutations. C. Rules for CNV-gene pairing at the borders. If
CNV falls on the boundary between two gene areas then we count
overlap for the gene that contain more than 50% of CNV length.
Second, we count overlap with the gene if it is entirely inside a CNV.
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each chromosome, we compose a “pseudo transcriptome”
made of concatenated genes (regions from transcription
start to transcription end positions) with flanking regions
(Figure 1B). For simplicity, for genes with multiple iso-
forms coordinates corresponding to the widest size are
considered. We then define a ‘gene area’ as the area that
spans the gene and upstream and downstream flanks.
S e c o n d ,w er e f i n et h eC N Vs e tb yr e t a i n i n go n l yC N V st h a t
overlap with gene areas. In case of partial overlap, the
CNV segment inside the gene area is retained (Figure 1B).
Third, the null distribution of enrichment is constructed
by permuting this new set of truncated CNVs on the tran-
scriptome by maintaining the number and size of CNVs
per chromosome. Last, we define simple rules to count
CNV-gene overlap as illustrated in Figure 1C; the gene area
is entirely within a CNV or the gene spans at least 50% of
a CNV. Finally, for each pathway, the p-value is calculated
by comparing the observed number of CNV-gene
overlaps with the empirical null distribution constructed
by the permutations.
It is important to mention few aspects that were not
considered in the implementation of the null distribu-
tion. First, the utilized CNVs genomic distribution infor-
mation is limited by the use of array-based platforms.
Second, paralogous genes, likely relevant in the context
of segmental duplications where CNVs are significantly
enriched, were not considered. More refined approaches
should eventually address these limitations.
The Size Dependent Enrichment Test executable and
source code is downloadable at: http://demichelislab.
unitn.it/tools/SizeEnrichmentTest.tar.gz.
Graphical representation of pathway related to CNV
frequencies across populations
For each pathway, we considered the subset of genes
overlapping with CNVs based on the gene areas (defined
above) and represented it with the corresponding set of
CNV-gene pairs. Based upon the systematic analyses of
short- and long-range effect of CNVs on gene transcript
levels [3,20,21], we considered 10 kb and 1 Mb flanks and
composed two CNV-gene frequency maps. The 10 kb
flanks map will capture the majority of the significant asso-
ciations between CNVs and genes (Stranger et al. 2007)
and the 1 Mb flanks map will include longer distance
effects. We used 10 kB flanks for size-dependent enrich-
ment/depletion analysis, and 1 Mb flanks for CNV asso-
ciation analysis with gene expression levels. For population
differentiation analysis at the level of individual genes and
of pathways we used 10 kb flanks to link genes and CNVs.
For population differentiation analysis of genes and path-
ways linked to “functional” CNVs we used 1 Mb flanks.
One CNV can overlap multiple genes and vice-versa one
gene can encompass (‘hit by’) several CNVs. Therefore the
number of CNV-gene pairs is not necessarily bound by the
number of CNVs. Using 10 kb flanks we counted 5,282
genes paired with CNVs and using 1 Mb flanks we counted
21,378 genes paired with CNVs.
Heatmaps were used to graphically represent the
CNV polymorphism frequency in each population,
with CNV-gene pairs in rows, and populations in columns
(YRI, CEU, and ASN). Hierarchical clustering (complete
linkage with Euclidean distances) was applied to identify
groups of similar CNV-gene frequencies across the three
populations.
Gene expression data and association analysis between
CNVs and gene expression levels
RNA-seq data for CEU and 69 YRI HapMap individuals
were downloaded from [18] and [19]. Sequencing data
were originally generated using the Illumina Analyzer II
with 36-base and 35 or 46-base pairs, respectively. YRI indi-
vidual data were downloaded from http://eqtl.uchicago.edu,
CEU individual raw data were obtained from ArrayExpress
under accession numbers E-MTAB-197 and preprocessed
applying RSEQtools [44]. Association analysis between gene
expression data and CNVs was performed independently
for CEU and YRI individuals by cis analysis applying 1 Mb
flanks to each variant accordingly to [20]. Dosage effect
(linear model) and allelic effect of transcript levels versus
the copy number states were tested [21]. Multiple hypo-
thesis testing correction was evaluated by calculating the
False Discovery Rate (Benjamini 1995) on the p-values; 10%
and 5% thresholds were applied. We will refer to CNV-
gene pair with significant association between CNV states
and gene expression levels as functional CNV-gene pair.
Mechanisms of CNV formation
Mechanisms of CNV formation were inferred as described
in [21] and are divided in four major classes: variable num-
ber of tandem repeats (VNTR), non-allelic homologous re-
combination (NAHR), transposable elements insertion
(TEI) and non-homologous recombination (NHR). Repeat-
Masker annotation tracks were downloaded from UCSC
browser to infer VNTR and TEI mechanisms. Two-sample
test of proportions was applied to assess the significant
differences in proportions of mechanism formation classes
for CNVs differentiated in populations.
Results
CNVs enrichment/depletion analysis at the level of
pathways
We analyzed all annotated pathways from KEGG [41] and
Biocarta (www.biocarta.com) (N=491) for CNV enrich-
ment. For each pathway, we identified a set of CNV-gene
pairs based on genomic co-location and applied size-
dependent enrichment/depletion analysis (see Methods).
The list of significantly enriched pathways is given in Table 1
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distribution of enriched KEGG functional classes and
Biocarta categories are presented in Figure 2. Despite
the general belief that CNVs are enriched mostly in
extracellular and signaling pathways [3,45], our results
indicate significant enrichment in key metabolic pathway
classes, such as carbohydrate (Pentose and glucuronate
interconversions and Inositol metabolism), xenobiotic
(Carbazole degradation, Fluorene degradation and
Metabolism of xenobiotics by cytochrome P450) and
glycan (Peptidoglycan biosynthesis) metabolisms (see
Table 1). Among the metabolic pathways that are
enriched in CNVs are the pathways from amino-acid
(Urea cycle and metabolism of amino groups, Cyanoamino
acid metabolism and Glutathione metabolism) and energy
(Sulfur metabolism) metabolisms.
Enriched signaling pathways include Keratinocyte diffe-
rentiation (16 genes out of 18, size-dependent enrichment
test) and Phospholipase C d1 in phospholipid associated
cell signaling (4 genes out of 5, size-dependent enrichment
test) (see Table 1). The list of depleted pathways and distri-
bution of KEGG and Biocarta functional classes is given in
Additional file 2: Table S1 and Additional file 3: Figure S1.
Distribution of the depleted pathway classes is similar with
that of all pathway classes in both databases.
Focusing on the pathways enriched for the presence of
CNVs, we compared the overall proportions of four
CNV formation mechanisms and found evidence for
enrichment of NHR (1.12 fold, P-value= 0.00014) and
depletion of TEI (0.63 fold, P-value= 0.0019) forma-
tion classes. With respect to CNV types, gains or
losses, depletion was observed for losses (0.89 fold,
P-value= 0.0055) and enrichment for gains (1.19 fold,
P-value= 0.0050).
Population differentiation at the level of individual genes
and of pathways
Population differentiation analysis was performed for
each CNV and each population pair-wise, by evaluating
the F-statistics (0, completely undifferentiated and 1,
highly differentiated) [42] (see Additional file 4: Table S2).
Overall 290 differentiated CNV-gene pairs were detected
at 5% significance level and 57 differentiated CNV-gene
pairs were detected at 1% significance level, including
previously reported genes [3,27,42,45,46]. The CNV-gene
pairs with the highest differentiation at 1% significance
level are presented in Table 2. The distribution of CNV
frequency differences for each pair of populations is
presented in Additional file 3: Figure S2. The data show
that frequency differences are higher between Yoruban
and the two other populations than between Europeans
and Asians, supporting the observation in [28]. The same
trend is observed in the distribution of allele frequency
differences for SNPs [47].
Gene expression levels are also subject to selection in the
human genome [48]. At the level of individual genes, the
selection acting on a CNV could be linked to transcription
levels associated with the CNV states. At the level of path-
ways, signatures of selection can be traced through the
selection acting on individual genes constituting the path-
way. To investigate the extent of population differentiation
on a pathway basis, we constructed pathway frequency
maps (see Methods) that combine polymorphism fre-
quencies of each CNV-gene pair in each population
Table 1 List of pathways enriched for CNV-gene pairs through size-dependent analysis (10 kb flanks)
Pathway Source Gene CNV Gene total P-value Fst
1 Antigen processing and presentation KEGG 29 79 <0.001
2 Metabolism of xenobiotics by cytochrome P450 KEGG 22 60 <0.001 0.31(CEU|YRI),0.23(YRI|CHB),0.16(CEU|CHB),
3 Type I diabetes mellitus KEGG 17 41 <0.001
4 Keratinocyte Differentiation BIOCARTA 16 18 <0.001 0.53(CEU|YRI), 0.57(YRI|CHB)
5 Pentose and glucuronate interconversions KEGG 9 14 <0.001 0.16(CEU|CHB), 0.28(YRI|CHB)
6 The role of FYVE-finger proteins in vesicle transport BIOCARTA 6 7 <0.001 0.12(CEU|YRI), 0.37(CEU|CHB),0.47(YRI|CHB),
7 Phospholipase C d1 in phospholipid associated cell
signaling
BIOCARTA 4 5 <0.001 0.53(CEU|YRI), 0.67(YRI|CHB),
8 Activation of cAMP-dependent protein kinase, PKA BIOCARTA 2 3 <0.001
9 B Cell Receptor Complex BIOCARTA 1 2 <0.001
10 Carbazole degradation KEGG 1 1 <0.001
11 Fluorene degradation KEGG 1 2 <0.001
12 Inositol metabolism KEGG 1 2 <0.001
13 Peptidoglycan biosynthesis KEGG 1 2 <0.001
14 Segmentation Clock BIOCARTA 7 12 0.001
* Column Fst lists the highest Fst value for each population pair. For the full list of pathways with CNV-gene pair annotation and corresponding Fst values, see
Additional file 2: Table S1.
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Additional file 3: Figure S3). Examples of pathway fre-
quency maps are depicted in Figure 3A and 3C. Focusing
on the Apoptosis pathway, we observed that AKT3 and
IKBKB related CNVs exhibit higher frequency of poly-
morphisms in the Yoruban population compared to the
European and Asian populations. TSTA3, B4GALNT4
and SORD CNV-gene pairs show significant population
differentiation in the map for Fructose and Mannose
metabolism, and UGT2B15, UGT2B17, UGT2A1 CNV-
gene pairs are seen as highly differentiated in the map for
Androgen and Estrogen metabolism (Figure 3)C.
T h ea n a l y s i so fa l lp a t h w a yC N V - g e n ef r e q u e n c ym a p s
(see Additional file 3: Figure S3) suggested a characteristic
pattern. Generally, a small proportion (6% on average) of
CNV-gene per pathway show strong population differen-
tiation (at least one CNV-gene pair in the pathway has
significant population differentiation) while the remaining
CNV-gene pairs are weakly differentiated or undifferen-
tiated as we can observe for Apoptosis, Fructose and
Mannose metabolism and NF-kb signaling pathway
(Figure 3C). A total of 107 pathways exhibited population
differentiation in the sense that at least one CNV-gene
pair is differentiated (P<0.05), among them 41 pathways
showed the highest population differentiation (P<0.01).
This list includes the Purine metabolism (P<0.01), the
Starch and sucrose metabolism (P<0.01), the Pentose and
glucuronate interconversions (P<0.01), and other highly
differentiated metabolic pathways (see the full list in
Additional file 5: Table S3).
Figure 4A presents a Venn diagram of the differentiated
pathways for each population pair. The corresponding
lists are given in Additional file 6: Table S4. Among the
metabolic class pathways, the Valine, leucine and isoleu-
cine degradation (P<0.05), the Glycerolipid metabolism
(P<0.05) and the Purine metabolism (P<0.01) show signifi-
cant differentiation between only European and Yoruban
populations; pathways such as Arginine and proline
metabolism (P<0.05), Pyrimidine metabolism (P<0.05),
ER-associated degradation (ERAD) pathway (P<0.05),
Alkaloid biosynthesis (P<0.05), Glycan structure biosyn-
thesis (P<0.05) and Glycosylphosphatidylinositol(GPI)-
anchor biosynthesis (P<0.05) show differentiation between
only Yoruban and Asian populations; the Pentose and glu-
curonate interconversions (P<0.01), the Starch and sucrose
metabolism (P<0.01), the Androgen and estrogen metabo-
lism (P<0.01), the Porphyrin and chlorophyll metabolism
(P<0.01), the Metabolism of xenobiotics by cytochrome
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Figure 2 Distribution of enriched KEGG and Biocarta pathway classes.A . Distribution of enriched KEGG classes. Original distribution of
pathway classes in KEGG database is given on the left. Distribution of the KEGG classes enriched (p-value < 0.05) in CNVs that were obtained with
the size-dependent enrichment analysis is given on the right. B. Distribution of enriched Biocarta categories. Original distribution of pathway
categories in Biocarta database is given on the left. Distribution of the Biocarta categories enriched (p-value < 0.05) in CNVs that were obtained
with the size-dependent enrichment analysis is given on the right.
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between only European and Asian populations. The
Metabolism of xenobiotics by cytochrome P450 is a
metabolic pathway that is also significantly (P<0.05)
differentiated between all three population pairs. Similarly,
a Venn diagram for the differentiated CNV-genes from the
above mentioned pathways is depicted in Figure 4B and the
corresponding list of unique and shared genes for each
population pair is given in Additional file 7: Table S5. 45
genes were detected as population differentiated with
P<0.05, among them 9 genes are highly differentiated
(P<0.01): ADCY8, ADRA1B, GRID2, IKBKB, POLB, SLIT2,
TFRC, UGT2B15, UGT2B17. The gene that showed poly-
morphic copy number states in all three populations and
significant population differentiation (P<0.05) in two popu-
lation pairs (CEU-YRI and CEU-ASN) is SORD. SORD
encodes the sorbitol dehydrogenase enzyme and partici-
pates in the Fructose and mannose metabolism pathway
(see heatmap in Figure 3C). SORD converts sorbitol to
fructose, and the latter can then be metabolized via the
glycolytic pathway to produce adenosine triphosphate
(ATP). The polymorphism frequency of the SORD CNV-
gene pair is 97% in the YRI population, 16% in the CEU
population, and 66% in ASN population. The CNV is
located in the first gene intron that often contains regula-
tory elements, however, we did not find evidence for regula-
tory elements based on the ENCODE histone marks data.
We tested for significant differences between proportions
of CNV formation mechanisms for population differen-
tiated CNVs and found that the proportion of TEI class
was significantly higher (1.85-fold, P-value=2.2e-16) while
that of VNTR and NHR was significantly lower (0.25-fold,
P-value= 1.773e-06 and 0.88 fold, P-value= 8.496e-07).
Proportion of NAHR class was not significantly different in
the three population pairs.
Association of CNVs with gene expression at the level of
genes and pathways
The proximity between a CNV and a gene can be consi-
dered an indicator for transcription regulation effect. How-
ever, this only occurs for a fraction of variants. To better
assess the potential regulator effect of CNVs on gene tran-
scripts, we considered RNA sequencing gene expression
data from 60 CEU [18] and 69 YRI [19] individuals (see
Methods) as in [21]. Overall, we detected significant CNV
gene expression association (FDR < 5%) involving 54 func-
tional CNV-gene pairs in CEU of which 16 could be
mapped to 24 pathways, and 37 functional CNV-gene pairs
in YRI of which 8 genes could be mapped to 14 pathways.
Focusing on the set of functional CNV-gene pairs, we
performed CNV enrichment/depletion analysis (using
Hypergeometric test) for the set of 24 pathways in CEU
and 14 pathways in YRI (Additional file 8: Table S7) and
found a significant enrichment of functional CNV-gene
pairs for one pathway, the Atrazine degradation pathway, in
CEU and for 14, mostly metabolic, pathways in YRI. The
latter includes Glutathione metabolism, Starch and sucrose
metabolism, Cyanoamino acid metabolism, Androgen and
estrogen metabolism and others (see the full list in
Additional file 8: Table S7).
Then we focused on functional CNV-gene pairs, which
were characterized as significantly differentiated among
populations. Out of 81 (in CEU and YRI combined)
functional CNV-gene pairs, 13 (16%) showed significant
population differentiation (P<0.05), and thus, are poten-
tial candidates for positive selection. Of the genes linked
Table 2 List of top ranked CNVs (gene overlap using
10 kb flanks) for population differentiation (at 1%
significance level, see Methods for cutoff values in three
population pairs)
CNV Overlapping genes F-stat Pairs
CNVR2664.1 ADRA1B 0.53; 0.67 CEU-YRI; YRI_ASN
CNVR3865.1 IKBKB
1,POLB 0.53; 0.57 CEU-YRI; YRI-ASN
CNVR1543.1 CPNE4 0.52; 0.37 YRI-ASN; CEU-YRI
CNVR1708.1 TFRC 0.47; 0.37 YRI-ASN; CEU-ASN
CNVR371.1 YY1AP1,DAP3 0.47; 0.37 CEU-YRI; YRI-ASN
CNVR2217.1 PDLIM3
1 0.47; 0.32 CEU-YRI; YRI-ASN
CNVR544.1 SLC35F3
2 0.46; 0.72 CEU-ASN; YRI-ASN
CNVR1648.3 KCNMB2 0.41; 0.77 CEU-YRI; YRI-ASN
CNVR6782.1 CNTNAP4 0.41; 0.31 YRI-ASN; CEU-YRI
CNVR7114.8 KIAA1267 0.4; 0.3 CEU-YRI; CEU-ASN
CNVR995.1 TUBA3D 0.39; 0.37 CEU-YRI; YRI-ASN
CNVR8147.1 HMGXB4 0.39; 0.36 CEU-YRI; YRI-ASN
CNVR1373.1 PRSS45 0.37; 0.31 CEU-YRI; YRI-ASN
CNVR3347.1 BBS9 0.35; 0.35 CEU-ASN; YRI-ASN
CNVR2152.1 TLL1 0.32; 0.34 CEU-YRI; YRI-ASN
CNVR4440.1 TXN 0.54 YRI-ASN
CNVR2807.2 FLJ22536 0.53 CEU-ASN
CNVR3563.1 GCC1 0.49 YRI-ASN
CNVR3398.2 PSPH 0.47 CEU-YRI
CNVR1841.1 SLIT2 0.46 YRI-ASN
CNVR95.2 PADI4 0.43 YRI-ASN
CNVR2906.1 C6orf142 0.42 CEU-YRI
CNVR7722.1 LILRA3 LILRA5 0.42 YRI-ASN
CNVR6372.1 SORD 0.42 CEU-YRI
CNVR5162.1 C11orf49 0.41 CEU-YRI
CNVR6117.1 KIAA0391 0.41 YRI-ASN
CNVR203.1 L1TD1 0.4 YRI-ASN
CNVR1009.1 ZRANB3 0.4 CEU-YRI
* The index refers to the original study where the gene has already been
reported for population differentiation.
1 [3].
2 [45].
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Figure 3 CNV-gene frequency heatmaps A. CNV-gene frequency heatmap for Basal transcription factors pathway and example of the significant
gene variant association for TAF4B gene from this pathway taken from YRI RNA-seq data. In the heatmap, rows correspond to CNV-gene pairs and
columns correspond to three Hapmap populations: YRI, CEU and ASN. The values of the heatmap are CNV polymorphism frequency (see
Methods). Evidence for population differentiation is given below the box plots. The schematic diagram shows connection of the gene TFA4B
with NF-kB signaling pathway (see text for explanations). B. Example of the significant gene variant association for APOBEC3B gene taken from CEU
RNA-seq data. Evidence for population differentiation is given below the box plots. Schematic diagram shows connection of the gene APOBEC3B
with Alu/L1 retrotransposition (see text for explanations). C. Examples of CNV-gene frequency heatmaps for four pathways: Apoptosis, Fructose and
mannose metabolism, NF-kb signaling pathway and Androgen and estrogen metabolism. Here flanking areas for CNV-gene pairs are 10 kb.
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tiation (P<0.05), 4 genes (UGT2B17, KRT39, APOBEC3B,
and TAF4B) are involved in 8 known pathways
(Additional file 9: Table S6): the Androgen and estrogen
metabolism, the Metabolism of xenobiotics by cytochrome
P450, the Pentose and glucuronate interconversions, the
Porphyrin and chlorophyll metabolism, the Starch and
sucrose metabolism, the Cell Communication, the Basal
transcription factors, and the Atrazine degradation. The
highest population differentiation (P<0.01) among func-
tional CNVs was detected for 2 CNV-gene pairs: one is for
the gene FAM128A, and the other for the gene TAF4B
from the Basal transcription factors pathway. Illustrations
of significant associations between CNV and gene expres-
sion are presented for the gene TAF4B belonging to the
Basal transcription factors pathway from YRI data
(Figure 3A) and for the gene APOBEC3B belonging to the
Atrazine degradation pathway from CEU data (Figure 3B).
TAF4B encodes a subunit of transcription initiation factor
that has been shown to function as co-activator of genes
from NF-kB signaling pathway [49]. Functional CNV for
TAF4B is 4 kb large and located 58 kb upstream the gene
of 165 kb. Observed CN states are 2, 3, and 4, and the ex-
pression is the highest for CN equal to 2. CNV population
frequencies are 89% in YRI, 15% in CEU, and 42% in ASN.
T h eg e n eA P O B E C 3 Bi sag e n ef r o mc y t i d i n ed e a m i n a s e
family performing C to U RNA-editing. It has been known
as an antiviral factor that can act against retroviruses, such
as HIV [50], and it has been also found to act as an inhibi-
tor of L1 and Alu retrotranspositon [51]. Functional CNVs
for APOBEC3B is 36 kb large and completely removes the
gene which is 10 kb in size. Population frequencies are
13% for CEU, 7% for YRI, and 54% for ASN.
Illustrations of associations, though not statistically
significant, between CNV and gene expression for genes
from the Mitogen-activated protein kinase (MAPK)
signaling pathway are presented in Additional file 3:
Figure S5. Associations were detected for two genes
located consecutively in the pathway chain: first gene is
from the CACNG family of gamma subunits important for
regulating calcium channels [52], and the second belongs
to RASGRP family that activates MAP kinase cascade.
Discussion
In this study, we performed a comprehensive size-
dependent analysis of the impact of common CNVs on
491 biological pathways across human populations, with
the idea that abundance of genetic variation in pathways
can be indicative of ongoing evolution. We first showed
that CNV enriched pathways include not only signaling
pathways and pathways involved in extracellular biological
processes [3], but also metabolic pathways such as amino-
acid, carbohydrate, energy and glycan metabolisms. The
Glycan biosynthesis pathway is annotated as originated in
vertebrates in a recent phylogenetic study of metabolic
pathways in the context of evolution [53] and in the oran-
gutan genome paper [54]. Some of the CNV-gene pairs
we report are potential candidates for individual studies
intended to investigate pathway-related dysfunctions and
metabolic diseases [55] (see Additional file 1).
In order to characterize the extent of human variation
at the level of each pathway, we compiled a comprehen-
sive list of population differentiated CNV-gene pairs. As
expected, the majority of pathways exhibiting population
differentiation, belong to the signaling class, including
Calcium, MAPK, Toll-like receptor signaling, and others.
Pathways from the metabolic class include Purine me-
tabolism, Arginine and proline metabolism, and Starch
and sucrose metabolism with the well documented ex-
ample of AMY1 polymorphism and its relation to starch
diet [30]. These findings provide evidence that signaling
pathways and pathways involved in extracellular activities
CEU-YRI YRI-ASN
CEU-ASN
67
40
15
51 24
8 14
7
63 84
CEU-YRI YRI-ASN
CEU-ASN
18
5
0
4 5
10 12
9
22 19
AB
Figure 4 Venn diagrams of the number of pathways and genes that show population differentiation. A. Venn diagram of the number of
pathways that have at least one gene that shows population differentiation (via CNV in 10 kb flank) (see the full list in the Additional file 6: Table S4). B.
Venn diagram of the number of genes that show population differentiation (via CNV in 10 kb flank. (see the full list in the Additional file 7: Table S5).
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of positive or adaptive selection [56]. Comprehensive
characterization of the influence of negative selection is
mandatory in future studies. Highly differentiated CNVs
overlapping or in proximity of genes indicate recent evolu-
t i o n a r ye v e n t s ,a n de m p h a s i z et h ei m p o r t a n c et oi m p r o v e
our understanding of selection forces that shape the
observed population differentiation [57]. Alternatively
genetic drift events [29] might be responsible for the
observed population differentiation, however their effect is
considered to be significant in small populations. Pathway
based analysis revealed CNV-gene pairs with intermediate
Fst in addition to highly differentiated CNVs. We reasoned
that this might correspond to ‘CNVs genetic hitchhiking’
similar to what was suggested by Barreiro [58] in the
context of SNPs.
Recent studies also indicated the pervasiveness of
negative, or purifying selection, acting on CNVs. Conrad
et al. [3] reported on purifying selection acting on exonic
and intronic deletions. Other studies reported on variants
under negative selection [58-60]. The methods used for
detection of purifying selection were based on the nucleo-
tide level resolution, and restricted solely to the genes.
Where our study focuses on the existence of significantly
differentiated pattern, it is relevant to highlight that appro-
priate distinction between positive and purifying selection
acting on CNVs is an important challenge that requires
extensive future work.
We then investigated pathway enrichment considering
the set of CNVs deemed functional through the association
between the corresponding transcript levels and the copy
number states and focused on those which also show diffe-
rentiation across populations. Despite the fact that the tran-
script analysis is limited due to the sample size, the
differences in the sequencing depth, and the sample type
(i.e., lymphoblast cells), we reasoned that our inte-
grated analysis would benefit from this additional
layer of information. Making a simplifying assumption, one
can consider that selection acting on transcript levels ulti-
mately influences the gene product leading to population
specific selective advantage, as it was shown for UGT2B17
and AMY1 in Asians and Europeans, respectively. Similarly,
the variant associated with APOBEC3B (Figure 3B) and
present at different frequenciesa c r o s sp o p u l a t i o n sm a ys u g -
gest a population specific antiviral effect, and in particular,
population specific effect on Alu-L1 retrotranspositional ac-
tivity. However, one has to consider that the detected po-
tential “functional” CNVs are not necessarily direct causal
variants and might simply be linked to the causal variants.
Throughout the study some well-known cancer-related
pathways were detected as enriched in population diffe-
rentiated CNVs (see Additional file 1). Even though most
of the detected genes have been extensively studied in
relation to cancer, their differential effect across
populations, including differential disease susceptibility, is
still to be investigated. The gene TAF4B, whose expression
levels are significantly associated with a population differ-
entiated CNV (Figure 3A) is a known co-activator of NF-
kB genes further stimulating NF-kB transcriptional activity
[61]. It was shown that functional consequences of NF-kB
signaling pathway is determined by NF-kB oscillation dy-
namics [62] and the number, period and amplitude of NF-
kB oscillations are regulated, via a negative feedback loop,
by transcription levels of IkBα. In a similar way, transcrip-
tion levels of TAF4B can regulate dynamics of NF-kB
genes, providing different functional outcomes for the
pathway. MAPK signaling pathway is another example of
how the tuning of enzyme concentration can affect signal-
ing pathway. We found population differentiated func-
tional CNVs for CANCG and RASGRP4 located upstream
of the MAPK pathway chain (Additional file 1 and
Additional file 3: Figure S5). The analysis of the model for
this pathway identified existence of two different dynamical
regimes, and depending on parameters, the system can
switch from single-state bi-stability to oscillations [63]. This
means that the MAPK signaling network can act as a
switch and as a clock, and the altered (tuned) element con-
centration levels can initiate such transition or prevent cyc-
ling due to a shift in the threshold positions.
The effect of gene concentration level changes on the cel-
lular phenotype and the concept of genetic balance has
been addressed in [64], together with the study of dosage-
sensitive genes documented in genomes of various species,
including yeast and human, and often encoding transcrip-
tion regulators, signal transduction elements and binding
factors [65]. However, we recognized that the complexity of
possible downstream changes relies on the non-linear
dynamics of biochemical reactions possibly leading to
non-proportional change in the concentration of the
final component [66].
Here we provide insights into human pathways
enriched for population differentiated functionally active
CNVs. Under the assumption that a pathway chain remains
intact as a whole (i.e., no new enzymes are added), we
hypothesize that evolutionary selected changes in
transcription level of some genes constituting the
pathway “tune” t h ep a t h w a yi n t oam o r ef a v o r a b l e
state for homeostasis, a process we refer to as the ‘tuning
effect’. Last, we suggest that new pathways can stem as
long-term potential outcome of the proposed tuning effect
(Additional file 1 and Additional file 3: Figure S6).
Conclusion
Upon the characterization of functional CNVs and the con-
comitant population differentiation of the same variants
suggestive of positive selection in different populations, it is
challenging to discover the real effect of these changes on a
pathway chain and to study the regulatory mechanisms in
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levels. The picture becomes more complicated by acknow-
ledging the multiplicity due to the existence of co-factors
concurring to gene regulation, to the presence of other
sources of variations, like epigenetic events, and by gene
regulation compensatory effects. Our analysis may help to
reveal pathway nodes, which have undergone changes
(positively, neutrally or negatively) in gene concentrations,
or, in other words, pathways that have been tuned. Further
studies are required to understand the impact of these and
other changes on pathway structure and human diversity.
Additional files
Additional file 1: Supplementary Material.
Additional file 2: Table S1. Size-dependent enrichment analysis results
for all the pathways considered in the study.
Additional file 3: Figure S1. Distribution of depleted KEGG and
Biocarta pathway classes. A. Distribution of depleted KEGG classes. Original
distribution of pathway classes in KEGG database is given on the left.
Distribution of the KEGG classes depleted in CNVs that were obtained
with the size-dependent enrichment analysis is given on the right.
B. Distribution of the depleted Biocarta categories. Original distribution of
pathway categories in Biocarta database is given on the left. Distribution
of the Biocarta categories depleted in CNVs that were obtained with the
size-dependent enrichment analysis is given on the right. Figure S2.
Histogram of CNV frequency differences in three population pairs: CEU-
YRI, CEU-ASN and ASN_YRI. CNV frequency is a frequency of
polymorphism and calculated as described in the Methods. Frequency
differences are given in absolute values. Figure S3. CNV-gene frequency
heatmaps for 368 pathways. Heatmaps are constructed for CNV-gene
pairs with 10 kb flanks. Figure S4. Rearrangements around SORD gene
area in human and chimpanzee. Figure shows Mauve block alignment of
four homologous regions in human and chimpanzee. First two regions
are extracted from human reference genome (build hg18):
chr15:43,080,000-43,163,000 and chr15:42,917,000-43,079,000, and the
second two regions are taken from chimpanzee genomes (build
panTro2): chr15:42,173,000-42,250,000 and chr15:41,950,000-42,030,000.
The region of ~ 80 kb that includes the gene SORD underwent inverse
duplication before the split of human and chimpanzee. The active copy
of the gene SORD is encoded on the plus strand and is shown in the
orange color. The copy of the gene SORD on the minus strand, that
most likely became a pseudogene, is shown in the light orange. CNV
resulted from a loss of a region in human genome from the inverted
copy of the gene SORD (see empty box at the second alignment row).
Analysis of the RepeatMasker annotation revealed that in the
chimpanzee, the L1 element (L1PA3) is located right next to the CNV
boundary. In the corresponding region in human, we see that the same
L1PA3 element was truncated from 50% of length to 15%, and the Alu
element (AluJb) was inserted just at the location of CNV. However, only
62% of Alu length remained in the sequence. The transposable elements
activity can also be seen in the promoter area of the gene SORD. The
remnants of retrovirus (HERV9, 50% of length) are present in the
promoter region of three copies of SORD except the active human copy
(first alignment row). Also, full length L1 element (L1PA6) that was most
likely inserted in the retrovirus, is observed upstream of the active copy
of the gene SORD, and the truncated copy of this element (65% of
length) remained upstream of the SORD pseudogene copy. Figure S5.
MAPK signaling pathway. A. CNV-gene frequency heatmap for MAPK
signaling pathway. Rows correspond to CNV-gene pairs and columns
correspond to three Hapmap populations: YRI, CEU and ASN. The values
of the heatmap are CNV polymorphism frequency (see Methods). B.
Schematic representation of a fragment of MAPK signaling pathway
(adopted from KEGG). Highlighted in orange are the gene families, CACN
and RASGRP, whose genes have CNVs with significant gene expression
associations (P-value<=0.01) and evidence for population differentiation.
Examples of gene variant associations for three genes from CACN family,
CACNG2, CACNG6 and CACNG7, are given in separate boxes. Example of
gene variant association for RASGRP family is given for RASGRP4 gene.
Figure S6. Tuning Effect of Pathway Evolution. Different color and shape
correspond to different enzymes. Increase in the concentration level of
one enzyme (here green) can induce changes in the concentration levels
of the linked enzymes (here blue and red). In the process of evolution, it
can lead to the recruitment of enzymes that perform better functions,
and as a result, create a new pathway.
Additional file 4: Table S2. Complete list of 4978 CNVs with Fst
calculated for each population pair.
Additional file 5: Table S3. List of pathways enriched for population
differentiated CNV-gene pairs.
Additional file 6: Table S4. List of unique and shared pathways for
Venn Diagram.
Additional file 7: Table S5. List of unique and shared genes for Venn
Diagram of Figure 4B.
Additional file 8: Table S7. Enrichment analysis for the functional CNVs
for CEU and YRI.
Additional file 9: Table S6. List of CNVs that showed significant
association with gene expression levels annotated with population
differentiation statistics, pathways information and annotation on overlap
with enhancers.
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